You are here: Home » Current Affairs » Coronavirus » News
Business Standard

More European nations including France, Germany halt AstraZeneca Covid vax

An additional number of European countries -- France Germany, Italy, Spain, Slovenia, Cyprus, Portugal -- have also suspended the use of the AstraZeneca Covid-19 vaccine over blood clot concerns

Coronavirus | Coronavirus Vaccine | AstraZeneca

IANS  |  Brussels 

Photo: Reuters
Photo: Reuters

An additional number of European countries -- France Germany, Italy, Spain, Slovenia, Cyprus, Portugal -- have also suspended the use of the Covid-19 vaccine over blood clot concerns.

The countries on Monday described the move as a precautionary measure pending a decision by the European Medicines Agency (EMA), which had greenlighted the use of the vaccine in the European Union (EU) on January 29, reports Xinhua news agency.

"The EMA is to give its opinion tomorrow afternoon. The decision that was taken (by France), in accordance with our European policy, is to suspend as a precaution the vaccination with AstraZeneca, hoping to resume it as soon as possible if the opinion is favourable," French President Emmanuel Macron said at a press conference on Monday.

In Berlin, Health Minister Jens Spahn cited a recommendation issued by the Paul Ehrlich Institut (PEI), an agency of the Health Ministry, referring to new reports of thromboses of the cerebral veins in connection with the jabs.

The Italian Pharmaceutical Agency (AIFA) said its "temporary and precautionary" ban on the vaccine followed the death of a music professor in the Piedmont region after he was given an shot.

A probe on this case has been opened in the city of Biella.

In Cyprus, a Health Ministry spokesman said the suspension will last only until Thursday.

The Ministry sought to allay concern among people who have already received the vaccine, repeating an earlier statement that there is no solid evidence that the AstraZeneca vaccine was to be blamed for the development of blood clotting.

Slovenian Health Minister Janez Poklukar told reporters that the country's expert group for vaccines had not found reasonable grounds to stop using the AstraZeneca vaccine. Nevertheless, as a matter of precaution, it is proposed that vaccination be suspended.

All those scheduled to receive the vaccine in the coming days will be rescheduled, whereas vaccination with the Moderna and Pfizer vaccines will continue as planned, he said.

In Spain, Health Minister Carolina Darias said "the thrombosis that the patients have suffered in the known cases is very specific".

At the same time, the minister highlighted the low risk from the vaccine, saying that "939,534 people in Spain have been inoculated with the vaccine" while only a single case of thrombosis has been reported.

EU member countries Austria, Bulgaria, Denmark, Romania, Estonia, Lithuania, Luxembourg, Latvia, the Netherlands and non-EU countries Norway and Iceland have already fully or partially suspended the use of the AstraZeneca vaccine following reports of suspected deaths from blood clots after vaccinations.

Globally, 263 candidate vaccines are still being developed worldwide, 81 of them in clinical trials, according to the World Health Organization.




(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, March 16 2021. 09:31 IST